LEKTI-2
LEKTI-2 LEKTI-2, also known as Lympho-Epithelial Kazal-Type Inhibitor 2, is a protein encoded by the SPINK9 gene in humans. It belongs to the serine protease inhibitor family and plays a crucial role in regulating protease activity in various tissues. Structure and Function LEKTI-2 consists of multiple Kazal-type serine protease inhibitor domains that enable it to inhibit the activity of serine proteases. These proteases are enzymes involved in various physiological processes, including blood clotting, inflammation, and digestion. By inhibiting serine proteases, LEKTI-2 helps maintain the balance of protease activity in the body. Role in Skin Barrier Function In the skin, LEKTI-2 is essential for maintaining the integrity of the epidermal barrier. It regulates the activity of proteases involved in skin desquamation, the process of shedding dead skin cells. Disruption of LEKTI-2 function can lead to skin disorders characterized by abnormal desquamation, such as Netherton syndrome. Clinical Implications Mutations in the SPINK9 gene encoding LEKTI-2 have been associated with skin disorders and impaired skin barrier function. Understanding the role of LEKTI-2 in skin biology is crucial for developing targeted therapies for these conditions. Research and Future Directions Research on LEKTI-2 continues to uncover its significance in skin health and disease. Further studies are needed to elucidate the precise mechanisms by which LEKTI-2 regulates protease activity and to explore its potential therapeutic applications in dermatology. References 1. Chavanas S, Bodemer C, Rochat A, et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet. 2000;25(2):141-142. 2. Descargues P, Deraison C, Bonnart C, et al. Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat Genet. 2005;37(1):56-65.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD